Trial intelligence / Profile preview

Local Uterine LMWH in ICSI

NCT02325479Phase 1Completed

Sponsor
Egyptian IVF-ET Center
Start
Jan 2015
Primary completion
May 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of enoxaparin in infertility, sponsored by Egyptian IVF-ET Center. Primary endpoint: Pregnancy Rate at 14 days. Started Jan 2015; status: completed.

02

Drugs

enoxaparin
03

Conditions

infertility

Beyond the preview

Go deeper on NCT02325479.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02325479.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call